Press Releases
Empliciti (elotuzumab) for the Treatment of Multiple myeloma treatment from Bristol-Myers Squibb and AbbVie scores EU approval
First and only immunostimulatory antibody approved in the European Union for multiple myeloma Accelerated assessment and approval based on long-term data from...
News
Shire Plc to Present New Research at 2016 American Psychiatric Association Annual Meeting
Shire plc will present new research on Binge Eating Disorder (B.E.D.) and Attention-Deficit/Hyperactivity Disorder (ADHD) at the upcoming 169th Annual Meeting of the American...
Press Releases
EC approves Immuno-Oncology Combination, Bristol-Myers Squibbs Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen, for Treatment of Advanced Melanoma
Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless of BRAF mutational status Approval of the Regimen marks...
Press Releases
Baxter to Present at the 2016 UBS Global Healthcare Conference
Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May 23 in New York, NY. Jay Saccaro, corporate vice...
News
Eli Lilly and Company marks 140 years of caring and discovery
Contributions to global health include insulin, penicillin, polio vaccine; continues quest for potential new medicinesEli Lilly and Company will commemorate its 140th anniversary today...
Industry Reports
Bayer, BioNTech collaborate to develop mRNA vaccines & therapeutics for animal health applications
Bayer and BioNTech AG, a leading immunotherapy company headquartered in Mainz, Germany have entered into an agreement to develop novel, first-in-class mRNA vaccines and...
Press Releases
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read